About Henry Schein Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.henryschein.com/
Frequently Asked Questions
What is the 52-week range for HSIC?
The 52-week high is $92.18 and the 52-week low is $61.95.
What is the P/E ratio for HSIC?
The Price to Earnings (P/E) ratio is 23.25.
What is the dividend yield for HSIC?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 12.37%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 2.96%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.77.
Analyst Recommendation Trends
Wall Street analyst consensus for HSIC over the last few months:
Latest HSIC News
Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry Schein
The global dental implants and prosthetics market is projected to grow from USD 12.79 billion in 2026 to USD 17.67 billion by 2031, at a 6.7% CAGR. Growth is driven by rising tooth loss, an aging population, demand for cosmetic dentistry, and advances in CAD/CAM, 3D printing and minimally invasive procedures. Dental implants and dental hospitals & clinics led the market in 2025, while Europe held the largest regional share. High treatment costs, limited reimbursement and shortages of skilled den
Cardinal Health: I'm Still Buying After Checking The Numbers
Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. Read more on CAH stock here.
Henry Schein Cares Marks 25 Years of Helping Health Happen®
MELVILLE, N.Y., September 30, 2026--Henry Schein Cares, Henry Schein, Inc.’s global corporate citizenship program, is celebrating a quarter century of bringing together Team Schein Members, customers, supplier partners, healthcare professionals, nonprofit organizations, and communities to help make the world healthier.
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings?
Henry Schein trades at $86.39 and has moved in lockstep with the market. Its shares have returned 18.8% over the last six months while the S&P 500 has gained 21.4%.
Henry Schein (HSIC) Extends Credit Facility, Is The Stock Still Undervalued?
Henry Schein (HSIC) is back in focus after amending and restating its revolving credit facility, increasing total commitments to $1.25 billion and extending the termination date to September 19, 2031. Against that backdrop, Henry Schein’s share price has moved to $86.37, with a 1-day share price return of 0.98% and a 7-day share price return of 1.80%. The 30-day share price return declined 3.52%, and the year-to-date share price return is 12.43%. The 1-year total shareholder return of 30.74%...
Henry Schein (HSIC) Stock Looks Below Fair Value Even After A 31% Gain
Henry Schein has delivered a 30.7% share price gain over the past year, which naturally puts the spotlight on whether that move is backed by the cash the business is expected to generate. With the stock recently closing at US$86.37, the key issue now is how that price lines up against the value suggested by its cash flows. The 30.7% return over the past 12 months raises a straightforward question for holders and potential buyers: whether the cash that Henry Schein can produce is enough to...
3 Cash-Producing Stocks That Concern Us
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Is Henry Schein Stock Outperforming the Dow?
Henry Schein has outperformed the Dow over the past year, and analysts are cautiously optimistic about the stock’s prospects.
Transcript: Henry Schein Q2 2026 Earnings Conference Call
Henry Schein (NASDAQ:HSIC) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Vistagen Therapeutics (NASDAQ:VTGN) shares increased by
Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher
Henry Schein remains a dominant global provider of dental and medical practitioner supplies. Find out why HSIC stock is a buy.
Are Investors Undervaluing Henry Schein (HSIC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Thursday's session: gap up and gap down stock in the S&P500 index
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
What Makes Henry Schein (HSIC) a New Buy Stock
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Henry Schein: Growth Is Improving, But The Valuation Stays Cheap
Henry Schein has been regarded as a large, slow-growing, low-margin distributor of dental supplies. Find out why HSIC stock is a buy.
Henry Schein, Inc. (HSIC) Presents at 2026 Global Healthcare Conference Transcript
Henry Schein, Inc. (HSIC) 2026 Global Healthcare Conference September 15, 2026 12:15 PM EDTCompany ParticipantsFrederick Lowery - CEO & DirectorRonald...
DermaSensor Raises $5 Million and Opens Round to the Public via Wefunder, Alongside Four Major New US Partnerships
MIAMI, September 09, 2026--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, announced today the close of a $4M Series B extension, including institutional and strategic investors, alongside the launch of a community investment round on Wefunder. This new community financing has already raised more than $1 million at the same terms as the $4M. This follows the company’s $16M Series B, closed in 2025, and brings the total investment in the company to $48 million.
Henry Schein to Participate in Upcoming Investor Conference in September
MELVILLE, N.Y., September 08, 2026--Henry Schein, Inc., the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conference in September:
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-08 | Albertini Andrea | -3,984 | - | - |
| 2026-09-08 | Albertini Andrea | -603 | $88.86 | $53,583 |
| 2026-06-12 | DANIEL WILLIAM K | +2,215 | - | - |
| 2026-05-26 | BERGMAN STANLEY M | -50 | - | - |
| 2026-05-21 | BERGMAN STANLEY M | -50 | - | - |
| 2026-05-19 | BERGMAN STANLEY M | -1,040 | - | - |
| 2026-05-11 | DANIEL WILLIAM K | +10,000 | $69.19 | $691,900 |
| 2026-03-19 | Popeck Thomas C | -1,355 | $72.79 | $98,630 |
| 2026-03-17 | Ettinger Michael S | -1,000 | - | - |
| 2026-03-16 | Sheehy Christine Zayac | -463 | $74.61 | $34,544 |
| 2026-03-16 | Popeck Thomas C | -587 | $74.61 | $43,796 |
| 2026-03-16 | Albertini Andrea | -1,401 | $74.61 | $104,529 |
| 2026-03-16 | South Ronald N. | -5,216 | $74.61 | $389,166 |
| 2026-03-16 | Ettinger Michael S | -4,214 | $74.61 | $314,407 |
| 2026-03-16 | Ettinger Michael S | -1,300 | - | - |
| 2026-03-16 | MLOTEK MARK E | -5,928 | $74.61 | $442,288 |
| 2026-03-16 | BERGMAN STANLEY M | -50 | $74.61 | $3,731 |
| 2026-03-16 | BERGMAN STANLEY M | -400 | - | - |
| 2026-03-12 | BERGMAN STANLEY M | -970 | - | - |
| 2026-03-10 | KUEHN KURT P | -2,844 | $78.961 | $224,565 |
| 2026-03-06 | Sheehy Christine Zayac | +7,087 | - | - |
| 2026-03-06 | Popeck Thomas C | +53,206 | - | - |
| 2026-03-06 | Albertini Andrea | +60,631 | - | - |
| 2026-03-06 | South Ronald N. | +20,296 | - | - |
| 2026-03-06 | Lowery Frederick M. | +177,116 | - | - |
| 2026-03-06 | Lowery Frederick M. | +64,433 | - | - |
| 2026-03-06 | Ettinger Michael S | +27,061 | - | - |
| 2026-03-06 | MLOTEK MARK E | +27,061 | - | - |
| 2026-03-06 | MLOTEK MARK E | -300 | - | - |
| 2026-03-06 | KKR & Co. Inc. | +918,723 | - | - |
| 2026-03-06 | KKR North America XIII S.a r.l. | +918,723 | - | - |
| 2026-03-06 | Serota Scott Philip | +2,577 | - | - |
| 2026-03-06 | Faig Carole T | +2,577 | - | - |
| 2026-03-06 | Margulies Anne H. | +2,577 | - | - |
| 2026-03-06 | ALI MOHAMAD | +2,577 | - | - |
| 2026-03-06 | Tuckson Reed Vaughn | +2,577 | - | - |
| 2026-03-06 | HOMBACH ROBERT J. | +2,577 | - | - |
| 2026-03-06 | KUEHN KURT P | +2,577 | - | - |
| 2026-03-06 | DERBY DEBORAH | +2,577 | - | - |
| 2026-03-06 | HERRING JOSEPH L | +2,577 | - | - |
| 2026-03-06 | DANIEL WILLIAM K | +2,577 | - | - |
| 2026-03-06 | SHEARES BRADLEY T | +2,577 | - | - |
| 2026-03-06 | LASKAWY PHILIP A | +2,577 | - | - |
| 2026-03-06 | BERGMAN STANLEY M | +2,577 | - | - |
| 2026-03-06 | BERGMAN STANLEY M | -3,812 | - | - |
| 2026-03-06 | MLOTEK MARK E | -300 | - | - |
| 2026-03-05 | MLOTEK MARK E | -1,215 | - | - |
| 2026-03-05 | LASKAWY PHILIP A | -2,844 | $80.36 | $228,544 |
| 2026-03-04 | MLOTEK MARK E | -1,825 | $80.811 | $147,480 |
| 2026-03-04 | MLOTEK MARK E | -4,100 | $80.795 | $331,260 |
| 2026-03-02 | Lowery Frederick M. | +30,723 | - | - |
| 2026-03-02 | BERGMAN STANLEY M | -19,954 | $81.31 | $1,622,460 |
| 2026-03-02 | BERGMAN STANLEY M | -23,858 | $81.31 | $1,939,894 |
| 2026-02-27 | Sheehy Christine Zayac | -88 | $82.39 | $7,250 |
| 2026-02-27 | Sheehy Christine Zayac | -780 | - | - |
| 2026-02-27 | Popeck Thomas C | -137 | $82.39 | $11,287 |
| 2026-02-27 | Popeck Thomas C | -1,202 | - | - |
| 2026-02-27 | Albertini Andrea | -440 | $82.39 | $36,252 |
| 2026-02-27 | Albertini Andrea | -3,999 | - | - |
| 2026-02-27 | South Ronald N. | -709 | $82.39 | $58,415 |
| 2026-02-27 | South Ronald N. | -6,815 | - | - |
| 2026-02-27 | Ettinger Michael S | -914 | $82.39 | $75,304 |
| 2026-02-27 | Ettinger Michael S | -9,047 | - | - |
| 2026-02-27 | MLOTEK MARK E | -1,065 | $82.39 | $87,745 |
| 2026-02-27 | MLOTEK MARK E | -9,440 | - | - |
| 2026-02-27 | BERGMAN STANLEY M | -7,349 | $82.39 | $605,484 |
| 2026-02-27 | BERGMAN STANLEY M | -48,531 | - | - |
| 2026-02-27 | BERGMAN STANLEY M | -10,785 | $81.2 | $875,742 |
| 2026-02-26 | BERGMAN STANLEY M | -7,212 | $81.51 | $587,850 |
| 2026-02-26 | BERGMAN STANLEY M | -31,134 | $80.9 | $2,518,741 |
| 2025-12-10 | Albertini Andrea | -2,032 | $75.88 | $154,188 |
| 2025-12-05 | KKR & Co. Inc. | +350,430 | - | - |
| 2025-12-05 | KKR North America XIII S.a r.l. | +350,430 | - | - |
| 2025-11-25 | BERGMAN STANLEY M | -500 | - | - |
| 2025-11-24 | BERGMAN STANLEY M | -140 | - | - |
| 2025-11-19 | Ettinger Michael S | -71 | - | - |
| 2025-11-13 | BERGMAN STANLEY M | -1,030 | - | - |